Follow us Facebook Icon

News
Covid vaccine should be available for public by April 2021: Serum Institute CEO

20 November, 2020

Vaccine maker Serum Institute of India's CEO Adar Poonawalla on thursday said the Oxford Covid-19 vaccine shoud be available.Read more...

SII’s Adar Poonawalla on Covid vaccine, pricing and rollout at Hindustan Times Leadership Summit 2020

19 November, 2020

The opening session of the 18th edition of the Hindustan Times Leadership Summit saw an enlightening discussion of the Covid-19 pandemic.Read more...

COVISHIELD Completes Enrolment of Phase III clinical trials under partnership of ICMR and Serum Institute of India

11 November, 2020

The strategic alliance between the SII and the ICMR will advance India’s role in the global race to develop COVID-19 vaccines.Read more...

No safety concerns related to the Covishield vaccine trial: Serum chief

05 November, 2020

Adar Poonawalla, CEO of SII said preliminary results have shown that there are no immediate concerns pertaining to the Covishield vaccine.Read more...

Government Secures Vaccine Supplies For Half Of The Indian Population From Serum Institute And Novavax

03 November, 2020

In a major development, India and Brazil have secured the rights to buy enough quantities of COVID-19 vaccine.Read more...

Adar Poonawalla speaks to NDTV about the coronavirus vaccine and it's development

28 October, 2020

Adar Poonawalla, CEO of Serum Institute of India in an exclusive interview with NDTV's Vishnu Som.Read more...

Coronavirus Vaccine shot painless say Covishield trial volunteers

12 October, 2020

The trial involves 1,600 volunteers in 17 cities across the country.Read more...

Serum Institute Of India Takes A Multipronged Approach In Quest To Produce Worlds First Covid-19 Vaccines

07 October, 2020

When the coronavirus pandemic broke out earlier this year, Adar Poonawalla, CEO of Serum Institute of India, the world’s largest vaccine maker by number of doses produced and sold, weighed the options.Read more...

SERUM INSTITUTE OF INDIA TO PRODUCE UP TO AN ADDITIONAL 100 MILLION COVID-19 VACCINE DOSES FOR INDIA AND LOW-AND MIDDLE-INCOME COUNTRIES IN 2021

29 September, 2020

The announcement takesforward the collaboration between the Serum Institute of India (SII), Gavi, the Vaccine Alliance and the Bill & Melinda Gates Foundation.Read more...

Adar Poonawalla CEO of Serum Institute of India, the world’s largest vaccine manufacturer, explains the timing, challenges & cost of vaccinating the world against COVID-19

23 September, 2020

Vaccine Update from the World’s Largest Vaccine Manufacturer Adar Poonawalla the CEO of Serum Institute of India joins Julia Chatterley to discuss the latest developments in their COVID-19 vaccine.Read more...

Serum Institute of India begins manufacture of Codagenix's nasal COVID-19 vaccine candidate

22 September, 2020

Serum Institute has received necessary regulatory approval from the Review Committee on Genetic Manipulation (RCGM) of India's Department of Biotechnology (DBT) for manufacturing Codagenix's COVID-19 vaccine candidate...Read more...

Oxford COVID-19 vaccine: Serum Institute to start final phase of trial in India from Monday

19 September, 2020

The phase III trial of 'Covishield' vaccine will begin at Sassoon hospital from next week, said Dr Muralidhar Tambe, Dean of Sassoon General Hospital...Read more...

Dr. Cyrus Poonawalla speaking on Vaccine Access in the Era of COVID–19

18 September, 2020

US drug developer Novavax Inc said on Tuesday it was doubling its potential COVID-19 vaccine manufacturing capacity to two billion doses annually...Read more...

Dr. Cyrus Poonawalla speaking on Vaccine Access in the Era of COVID–19

16 September, 2020

Dr. Cyrus Poonawalla speaking on Vaccine Access in the Era of COVID – 19 - Co Hosted by the Johns Hopkins India Institute...Read more...

Novavax-Serum Institute to produce for 200 crore Covid-19 vaccine doses

15 September, 2020

As a part of the expanded agreement, Serum Institute will also manufacture the antigen component of NVX‑CoV2373, Novavax’s Covid‑19 vaccine candidate...Read more...

Oxford vaccine trial pause won't have impact on Indian trials: Serum Institute CEO

13 September, 2020

The human trials resumed days after a pause had been announced in the trials after an adverse reaction in one of the participants...Read more...

Looking forward to the Oxford covid vaccine: Serum Institute CEO

08 September, 2020

The Oxford University-AstraZeneca covid vaccine is now undergoing Phase III clinical trials in Britain, Brazil, South Africa and India...Read more...

bangladeshs-beximco-signs-covid-19-vaccine-deal-with-indias-serum-institute

29 August, 2020

The deal announced by the Bangladeshi generic drugmaker comes after Dhaka said this month it was ready to hold trials of candidate vaccines being developed by India as both countries seek to curb the spread of the virus...Read more...

bloomberg-school-awards-highest-honor-to-poonawalla-and-casals

The Johns Hopkins University, Baltimore, USA has awaeded its highest honour to Dr. Cyrus Poonawalla...Read more...

oxford-covid-19-vaccine-serum-institute-begins-clinical-trial-in-india

26 August, 2020

The 'Covishield' vaccine's trials begin with the first patients screened by Bharati Vidyapeeth Deemed University (BVDU) Medical College and Hospital in Pune...Read more...

icmr-helping-serum-institute-in-conducting-clinical-trials-for-two-vaccines

20 August, 2020

Country’s apex biomedical research agency is also helping Zydus Cadila for laboratory assays to detect antibody response, according to documents reviewed by Mint...Read more...

oxford-covid-19-vaccine-final-trials-will-be-held-in-these-17-hospitals-in-india

19 August, 2020

A total of 1,600 candidates will take part in the study. King Edward Memorial Hospital Parel, and BYL Nair Hospitals, Mumbai Central — have received approval from ICMR to start the trial...Read more...

serum-institute-of-india-to-begin-phase-2-trials-of-oxford-covid-19-vaccine-this-week

18 August, 2020

Serum Institute of India (SII) will begin the phase 2 clinical trials of a promising coronavirus vaccine developed by the University of Oxford this week...Read more...

serum-institute-looking-for-a-$1-billion-shot-to-fight-covid-talks-on-with-Blackstone-KKR-and-others

18 August, 2020

​​The company, privately owned by Cyrus Poonawalla and his son Adar Poonawalla, plans to float a special purpose vehicle (SPV) for its vaccine candidates, ET has learnt...Read more...

the-worlds-best-hope-for-enough-covid-19-vaccine-comes-from-india

11 August, 2020

The Serum Institute of India is preparing to crank out a billion doses. And that's just the beginning...Read more...

serum-institute-of-india-says-covid-vaccine-likely-to-be-ready-by-end-of-2020-final-pricing-in-2-months

10 August, 2020

SII is part of the agreement with AstraZeneca, which along with Oxford University has developed a vaccine that has reported satisfactory progress from the test results...Read more...

Novavax signs COVID-19 vaccine supply deal with India’s Serum Institute

07 August, 2020

New landmark collaboration between the Serum Institute of India (SII), Gavi, and Bill & Melinda Gates Foundation...Read more...

Novavax signs COVID-19 vaccine supply deal with India’s Serum Institute

06 August, 2020

On Tuesday, Novavax reported that its experimental COVID-19 vaccine produced high levels of antibodies against the novel coronavirus in a small...Read more...

Serum Institute of India gets approval to start human trials for Oxford vaccine

01 August, 2020

Earlier this week, a committee of experts had deferred a decision on the request of SII to start trials and asked the company to amend its protocol for the clinical study...Read more...

Serum Institute conducting phase III clinical trial of BCG vaccine: DBT

27 July, 2020

About 6,000 health workers and high-risk individuals including those in close contact of COVID-19 patients have been enrolled in a clinical trial to determine...Read more...

Serum Institute of India CEO: ‘We plan to make millions of doses of Covid vaccine over three months’:’

22 July, 2020

Adar Poonawalla said if the vaccine trials go fine and the results are favourable, Serum Institute of India will be manufacturing this Covid-19 vaccine as a partner with Oxford University. Read more...

Serum Institute of India CEO: ‘We plan to make millions of doses of Covid vaccine over three months’:’

21 July, 2020

SII, the largest vaccine manufacturer in the world, has been chosen by Oxford and its partner AstraZeneca. Read more...

Serum Institute of India CEO: ‘We plan to make millions of doses of Covid vaccine over three months’:’

18 July, 2020

Serum Institute CEO Adar Poonawalla speaks to The Indian Express about their efforts to develop Covid-19 vaccines Read more...

First Fully Indigenous Pneumonia Vaccine, Developed By Serum Institute, Approved

15 July, 2020

New Delhi: The Drug Controller General of India (DCGI) on Wednesday approved the first fully indigenously developed Pneumococcal Polysaccharide Conjugate Vaccine developed by Serum Institute of India, Pune. Read more...

Serum Institute of India expects COVID vaccine by year-end

8 July, 2020

He was speaking during the launch of 'Compact XL, a compact diagnostics machine by MyLab Discovery Solutions, that will automate lab processes from sample handling to preparing RT-PCR tubes Read more...

serum institute of india to supply pneumonia vaccine to low income nations

17 June, 2020

Pneumonia is the biggest single killer of children, claiming the life of a child every 39 secondsRead more...

News

10 June, 2020

Our manufacturing facility is ready and we plan to start production in two months. We are spending more than USD 100 million for this facilityRead more...

News

05 June, 2020

The Pune-based company has executed the deal through its German subsidiary mPower GmbH.Read more...

News

04 June, 2020

World leaders make historic commitments to provide equal access to vaccines for all Read more...

News

05 June, 2020

The University of Oxford in partnership with AstraZeneca has taken the next steps in its commitment to broad and equitable global access to Oxford’s COVID-19 vaccine. Read more...

News

05 June, 2020

AstraZeneca is the latest deal that Pune-based Serum Institute has stitched together. How did the 50-year-old vaccine maker become the face of the Indian fight against COVID-19? Read more...

News

04 June, 2020

The British drug maker also reached a $750m agreement with Coalition for Epidemic Preparedness Innovation (CEPI) and Gavi to support the manufacturing, procurement Read more...

News

04 June, 2020

Poonawalla is betting big on a Covid-19 vaccine, and preparing for the next possible pandemic.Read more...

News

28 May, 2020

Serum Institute has currently joined hands with various global pharmaceutical institutes and firms in efforts to produce a vaccine for Covid-19 Read more...

News

28 April, 2020

In this episode of To The Point, RSTV Speaks to Adar Poonawalla, CEO and Owner, Serum Institute of India. As the world races to find a cure for the deadly novel coronavirus, Read more...

News

06 April, 2020

With Indian authorities expediting approvals, a viable Coronavirus vaccine may be commercially available earlier than anticipated. Read more...

News

02 April, 2020

As governments race to get a handle on the spread of the coronavirus and cure the affected people, the medical community has been busy workingRead more...

News

02 April, 2020

Pune-based molecular diagnostics company Mylab Discovery Solutions Pvt Ltd has partnered with Serum Institute of India’s CEO Adar Poonawalla and Abhijit Pawar,Read more...

News

01 April, 2020

Serum Institute of India has partnered with American biotechnology firm @Codagenix to develop a vaccine against COVID-19, and expects it to be ready by early 2022. Read more...

News

12 March, 2020

Adar Poonawalla talks with Aabha Bakaya about the success story of Serum Institute of India. Tune in to know all about the journey of the company. Read more...

News

10 March, 2020

Cyrus Poonawalla's Serum Institute has signed a joint venture with US company Codagenix to work on a coronavirus cure Read more...

News

07 March, 2020

Serum Institute of India, world’s largest vaccine producer by number of doses produced, headquartered in Pune, has stated that the vaccine for COVID-19 will not be readied before 2022. Read more...

News

19 December, 2019

This milestone marks a key step toward improving pneumococcal conjugate vaccine affordability and enabling sustainable access for low- and middle-income countries. Read more...

News

16 December, 2019

Serum Institute of India and Villoo Poonawalla Foundation have collaborated with the Camp Education Society to upgrade the infrastructure of two schools. Read more...

News

17 November, 2019

Dr. Cyrus Poonawalla was conferred with the Indian Council of Medical Research (ICMR) 'Lifetime Achievement Medal' for his outstanding contribution Read more...

News

06 November, 2019

Dr. Cyrus Poonawalla was conferred with the 'Lifetime Achievement Award’ by the Asian Business Leadership Forum (ABLF) at the awards ceremony held on 6th November 2019 in Dubai Read more...

News

09 September, 2019

Serum Institute of India's new plant inaugurated by Hon'ble Union Health Minister Dr. Harsh Vardhan. Read more...

News

26 June, 2019

Dr. Cyrus Poonawalla was conferred with the prestigious 'Degree of Doctor of Science, honoris causa' by the University of Oxford, U.K. at a glittering ceremony Read more...

News

10 December, 2018

Dr Cyrus Poonawalla, Founder of Serum Institute of India (SII) and Chairman of Poonawalla Group, has been given the first ever Vaccine Hero award by Gavi. Read more...

News

7 April, 2018

Mr Adar Poonawalla, CEO, Serum Institute of India, receiving the prestigious Read more...

News

November, 2017

Adar Poonawalla, CEO of Serum Institute received the Outsatanding achievement in Business & CSR from CNN-News18's Indian of the Year Read more...

News

8 September, 2017

Prime Minister Narendra Modi’s recent nomination of Pune industrialist Adar Poonawalla, as ambassador for the Swachh Bharat mission, comes in recognition of his major initiative towards a cleaner and greener Pune. Read more...

News

15 November, 2016

Adar Poonawalla's clean city initiative launched in collaboration with the Pune Municipal Corporation this January has struck a chord with Prime Minister Narendra Modi Read more...

News

13 November, 2016

Hon'ble Prime Minister Shri. Narendra Modi visited the Serum Institute of India on Sunday 13th November and met with the Chairman & Managing Director Dr. Cyrus Poonawalla and CEO Mr. Adar Poonawalla. Read more...

News

8 January, 2016

Rem With an aim to make Puce 100 per cent garbage free by the end of 2016, the Poonawalla Group's Serum Institute of India has collaborated with the Pune Municipal Corporation (PMC) Read more...